Patients with resistant hypertension attend the DCVR clinic which has been shown to achieve sustained reductions in blood pressure (BP) and total cholesterol 1. The objective of this study is to retrospectively assess the feasibility of data collection and define outcome measures to inform a future prospective randomised controlled trial (RCT) to evaluate the pharmacist-led DCVR clinic.
|Number of pages||1|
|Journal||International Journal of Clinical Pharmacy|
|Publication status||Published - 1 Oct 2013|
|Event||41st ESCP symposium on clinical pharmacy: personalised and safe therapy - Barcelona, Spain|
Duration: 29 Oct 2012 → 31 Oct 2012
- cardiovascular risk factors
- DCVR clinic